Issue 7, 2022

Structure and mechanism behind the inhibitory effect of water soluble metalloporphyrins on Aβ1–42 aggregation

Abstract

Although the exact molecular mechanism of the pathogenesis of Alzheimer's disease (AD) is still unclear, compounds that can inhibit the aggregation of amyloid-β peptide (Aβ1–42) or scavenge the highly toxic peroxynitrite (ONOO) free radical have been confirmed to delay or alleviate AD to a certain extent. Thus, the design and screening of dual-function compounds are important for biomedical aims. A group of water soluble metallopophyrins, including FeTMPyP, MnTMPyP, FeTBAP and MnTBAP, are well known active ONOO decomposition catalysts, which share the structural similarity of planar aromatic conjugation with a valuable class of inhibitors against amyloid fibrillation, although their effects on Aβ1–42 aggregation and toxicity have been less explored. Here, we aimed to investigate their inhibitory effects on Aβ1–42 aggregation, in particular, how this relates to the structure. Fluorescence and TEM results showed that cationic metalloporphyrins (FeTMPyP and MnTMPyP) exhibited a stronger inhibitory effect on Aβ1–42 fibrillation than anionic metalloporphyrins (FeTBAP and MnTBAP), and the metalloporphyrin with an iron center is more effective than the one with a manganese center. Cell experiments revealed that the protective effect of these metalloporphyrins on Aβ1–42-induced cytotoxicity is consistent with their anti-fibrillization activity. We also provide evidence that metalloporphyrins stabilize the Aβ1–42 monomer, resulting in interfering with its self-assembly. The electrostatic interaction between the tetraphenylporphyrin of a metalloporphyrin and an amyloid peptide determines the inhibitory effect of metalloporphyrins. However, for the same ligand porphyrin, Fe-porphyrin is more effective than Mn-porphyrin, which can be attributed to the additional coordination bond between the central metal atom (Fe) and the amyloid peptide. The conclusions were further confirmed by the use of another amyloid polypeptide (hIAPP) and other anionic metalloporphyrins (FeTPPS and MnTPPS). We believe that the findings will aid in the development of metalloporphyrin agents targeting AD and other amyloid diseases.

Graphical abstract: Structure and mechanism behind the inhibitory effect of water soluble metalloporphyrins on Aβ1–42 aggregation

Supplementary files

Article information

Article type
Research Article
Submitted
27 Nov 2021
Accepted
10 Feb 2022
First published
12 Feb 2022

Inorg. Chem. Front., 2022,9, 1520-1532

Structure and mechanism behind the inhibitory effect of water soluble metalloporphyrins on Aβ1–42 aggregation

Q. Zhang, Y. Liu, J. Wu, L. Zeng, J. Wei, S. Fu, H. Ye, H. Li and Z. Gao, Inorg. Chem. Front., 2022, 9, 1520 DOI: 10.1039/D1QI01434J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements